29 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... Papillomavirus (HPV ... A virus (HAV) infection ... virus (HBV) infection ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... Papillomavirus (HPV ... A virus (HAV) infection ... virus (HBV) infection ... #management #pharmacology
Immunizations for People Living with HIV (PLWH)
 • HPV
 • Hepatitis
 • Influenza
 • Meningococcal
 •
People Living with HIV ... (PLWH) • HPV ... Immunizations #PLWH #HIV ... #AIDS #management ... #primarycare
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... known to have HIV ... diagnosed with HIV ... regardless of mode of HIV ... • Women with HIV
Health Maintenance Checklist for Adult IBD Patients

Vaccine Preventable Diseases: Influenza (inactive), Pneumococcal PCV13, Pneumococcal PPSV23, Tdap,
PPSV23, Tdap, HPV ... A, Hepatitis B, ... Zoster Cancer Prevention ... gastroenterology #primarycare ... #screening #prevention
Alcoholic Hepatitis - Management Algorithm
Assess Eligibility for Treatment:
 - Maddrey Discriminant Function ≥ (or possibly MELD
Alcoholic Hepatitis ... other causes of jaundice ... diseases including HBV ... HCV, DILI, HCC, ... HIV, TB - Multiorgan
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... in HIV-AIDS Oropharyngeal ... candida #mucosal #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
and Treating HHV ... Disease (MCD) in HIV-AIDS ... and uncontrolled HIV ... activity against HHV ... #management #opportunistic
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV ... Infections in HIV-AIDS ... Mucocutaneous HSV ... HerpesSimplex #HSV ... #IDSA #Prevention
HIV PrEP (Pre-Exposure Prophylaxis) - Truvada 

HIV Pre-Exposure Prophylaxis (PrEP) is available in the form of
HIV PrEP (Pre-Exposure ... - Truvada HIV ... infected with HIV ... patients who have HIV ... /ambcarerx #HIV